about
The glomerulopathy of sickle cell diseaseAssociation of sickle cell trait with chronic kidney disease and albuminuria in African Americans.Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell diseasePersonalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.High prevalence of sickle cell trait in African Americans with ESRD.Sickle cell trait and incident ischemic stroke in the Atherosclerosis Risk in Communities study.Prospective study of sickle cell trait and venous thromboembolism incidenceVenous thromboembolism in patients with membranous nephropathySickle cell trait is not independently associated with susceptibility to end-stage renal disease in African AmericansSugar-sweetened soda consumption, hyperuricemia, and kidney disease.Sickle-cell trait: novel clinical significance.Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients.Rituximab therapy for membranous nephropathy: a systematic reviewCombined effects of AT(1) and ET(A) receptor antagonists, candesartan, and A-127722 in DOCA-salt hypertensive rats.Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent doseRenal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.The Case: Acute kidney injury in a patient with P. carinii pneumoniaAdenovirus causing fever, upper respiratory infection, and allograft nephritis complicated by persistent asymptomatic viremia.Sickle Cell Trait and the Risk of ESRD in Blacks.A Randomized Crossover Trial of Dietary Sodium Restriction in Stage 3-4 CKD.Patients with primary membranous nephropathy are at high risk of cardiovascular events.Polyomavirus nephropathy: quantitative urinary polyomavirus-Haufen testing accurately predicts the degree of intrarenal viral disease.A rare cause of the pulmonary-renal syndrome: a case of atypical haemolytic-uraemic syndrome complicated by pulmonary haemorrhage.Diagnostic significance of peritubular capillary basement membrane multilaminations in kidney allografts: old concepts revisited.Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET).Sickle cell trait is not associated with an increased risk of heart failure or abnormalities of cardiac structure and function.The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait.ANCA-Associated Vasculitis - Refining Therapy with Plasma Exchange and GlucocorticoidsRapid decline in estimated glomerular filtration rate is common in adults with sickle cell disease and associated with increased mortality
P50
Q27023071-79FE905C-B10B-4DC7-B1D9-0AAA7453E191Q30301317-7CCB4B82-3A32-4F38-8130-A7C0210FFB32Q33571802-B7B807C9-7D8C-4472-94E7-6A9D62A3B059Q33684601-6CA79F55-6463-482C-AB54-198D99C49871Q33692552-CD14DDF2-2A12-43C2-9CCB-5F8696A6C14EQ33702439-A88EAD86-25BD-42E0-9D1D-80BFF5E11CCFQ34241961-68986040-BC22-4560-BF44-CE3ED26C362BQ34964268-9906C59C-18EF-4FEC-8524-8E9EAFB70888Q35692422-017B58A7-B447-4929-B818-332859119896Q35759686-2832FC3E-3886-4B7D-AB4C-A87D5343D6C8Q35820430-8001C0B1-74A4-473D-BB75-D274815A36CFQ35820449-B7B2D21B-6672-4D61-9B3E-294C013AF065Q35851384-A08437EC-66A0-4C41-AAC7-971D7B2BF59CQ37412829-B6353DBF-2EE7-404E-B859-8D0BC534CD9BQ37612474-10229CCD-8C08-447F-AD81-5FC46921706AQ37670331-6C9F7634-32CC-4B17-9ECF-D3BBBC32C263Q39573370-EBEEE5FE-060E-47D2-B0B1-8FA25F227837Q39782321-57E246FE-9C75-455C-98F1-916EBA4A8021Q40202291-0C2DD2D5-F4BA-44BB-93DD-BC9A1BE77A75Q40298866-22D4D291-54CC-4AC4-80AB-CA2E79CE467CQ40331350-B76A626B-98DA-479D-A3AE-DF26637A71C8Q40882334-3206328D-CA9E-4DC1-9548-DBD41DED6208Q42199120-4AC8193A-5FE4-4D66-B236-5ABE526A07D1Q42540640-C33B6EDD-7509-4C80-BD40-3C11C279E7E5Q43116382-186ACFED-A972-44C6-9D0D-2B8250D2ED14Q46399341-774C5C8C-5CD5-4409-B7D2-0FCF735D9990Q46882893-760AE219-1DA0-4241-8B2A-3688EF59CC3AQ47129770-9D7DBE1B-2135-4CEC-BAF4-568280A08698Q89694438-9A3E82D6-617C-49C0-89D0-A7B75DACE8B3Q92553336-298FADB8-5F8C-44A1-926E-3DC4F1E4518D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Vimal K. Derebail
@ast
Vimal K. Derebail
@en
Vimal K. Derebail
@es
Vimal K. Derebail
@nl
Vimal K. Derebail
@sl
type
label
Vimal K. Derebail
@ast
Vimal K. Derebail
@en
Vimal K. Derebail
@es
Vimal K. Derebail
@nl
Vimal K. Derebail
@sl
prefLabel
Vimal K. Derebail
@ast
Vimal K. Derebail
@en
Vimal K. Derebail
@es
Vimal K. Derebail
@nl
Vimal K. Derebail
@sl
P106
P1153
6504612968
P21
P31
P496
0000-0002-7662-7497